The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015

Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, Allen C, Al-Raddadi R, Alvis-Guzman N, Amoako Y, Artaman A, Ayele TA, et al. (2017)
JAMA ONCOLOGY 3(12): 1683-1691.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ; ; ; ; ; ;
Alle
Abstract / Bemerkung
IMPORTANCE Liver cancer is among the leading causes of cancer deaths globally. The most common causes for liver cancer include hepatitis B virus (HBV) and hepatitis C virus (HCV) infection and alcohol use. OBJECTIVE To report results of the Global Burden of Disease (GBD) 2015 study on primary liver cancer incidence, mortality, and disability-adjusted life-years (DALYs) for 195 countries or territories from 1990 to 2015, and present global, regional, and national estimates on the burden of liver cancer attributable to HBV, HCV, alcohol, and an " other" group that encompasses residual causes. DESIGN, SETTINGS, AND PARTICIPANTS Mortalitywas estimated using vital registration and cancer registry data in an ensemble modeling approach. Single-cause mortality estimates were adjusted for all-cause mortality. Incidence was derived from mortality estimates and the mortality-to-incidence ratio. Through a systematic literature review, data on the proportions of liver cancer due to HBV, HCV, alcohol, and other causes were identified. Years of life lost were calculated by multiplying each death by a standard life expectancy. Prevalence was estimated using mortality-to-incidence ratio as surrogate for survival. Total prevalence was divided into 4 sequelae that were multiplied by disability weights to derive years lived with disability (YLDs). DALYs were the sum of years of life lost and YLDs. MAIN OUTCOMES AND MEASURES Liver cancer mortality, incidence, YLDs, years of life lost, DALYs by etiology, age, sex, country, and year. RESULTS There were 854 000 incident cases of liver cancer and 810 000 deaths globally in 2015, contributing to 20 578 000 DALYs. Cases of incident liver cancer increased by 75% between 1990 and 2015, of which 47% can be explained by changing population age structures, 35% by population growth, and -8% to changing age-specific incidence rates. The male-to-female ratio for age-standardized liver cancer mortality was 2.8. Globally, HBV accounted for 265 000 liver cancer deaths (33%), alcohol for 245 000 (30%), HCV for 167 000 (21%), and other causes for 133 000 (16%) deaths, with substantial variation between countries in the underlying etiologies. CONCLUSIONS AND RELEVANCE Liver cancer is among the leading causes of cancer deaths in many countries. Causes of liver cancer differ widely among populations. Our results show that most cases of liver cancer can be prevented through vaccination, antiviral treatment, safe blood transfusion and injection practices, as well as interventions to reduce excessive alcohol use. In line with the Sustainable Development Goals, the identification and elimination of risk factors for liver cancer will be required to achieve a sustained reduction in liver cancer burden. The GBD study can be used to guide these prevention efforts.
Erscheinungsjahr
Zeitschriftentitel
JAMA ONCOLOGY
Band
3
Zeitschriftennummer
12
Seite
1683-1691
ISSN
eISSN
PUB-ID

Zitieren

Akinyemiju T, Abera S, Ahmed M, et al. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015. JAMA ONCOLOGY. 2017;3(12):1683-1691.
Akinyemiju, T., Abera, S., Ahmed, M., Alam, N., Alemayohu, M. A., Allen, C., Al-Raddadi, R., et al. (2017). The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015. JAMA ONCOLOGY, 3(12), 1683-1691. doi:10.1001/jamaoncol.2017.3055
Akinyemiju, T., Abera, S., Ahmed, M., Alam, N., Alemayohu, M. A., Allen, C., Al-Raddadi, R., Alvis-Guzman, N., Amoako, Y., Artaman, A., et al. (2017). The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015. JAMA ONCOLOGY 3, 1683-1691.
Akinyemiju, T., et al., 2017. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015. JAMA ONCOLOGY, 3(12), p 1683-1691.
T. Akinyemiju, et al., “The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015”, JAMA ONCOLOGY, vol. 3, 2017, pp. 1683-1691.
Akinyemiju, T., Abera, S., Ahmed, M., Alam, N., Alemayohu, M.A., Allen, C., Al-Raddadi, R., Alvis-Guzman, N., Amoako, Y., Artaman, A., Ayele, T.A., Barac, A., Bensenor, I., Berhane, A., Bhutta, Z., Castillo-Rivas, J., Chitheer, A., Choi, J.-Y., Cowie, B., Dandona, L., Dandona, R., Dey, S., Dicker, D., Phuc, H., Ekwueme, D.U., Zaki, M.E.S., Fischer, F., Furst, T., Hancock, J., Hay, S.I., Hotez, P., Jee, S.H., Kasaeian, A., Khader, Y., Khang, Y.-H., Kumar, G.A., Kutz, M., Larson, H., Lopez, A., Lunevicius, R., Malekzadeh, R., McAlinden, C., Meier, T., Mendoza, W., Mokdad, A., Moradi-Lakeh, M., Nagel, G., Nguyen, Q., Nguyen, G., Ogbo, F., Patton, G., Pereira, D.M., Pourmalek, F., Qorbani, M., Radfar, A., Roshandel, G., Salomon, J.A., Sanabria, J., Sartorius, B., Satpathy, M., Sawhney, M., Sepanlou, S., Shackelford, K., Shore, H., Sun, J., Mengistu, D.T., Topor-Madry, R., Tran, B., Ukwaja, K.N., Vlassov, V., Vollset, S.E., Vos, T., Wakayo, T., Weiderpass, E., Werdecker, A., Yonemoto, N., Younis, M., Yu, C., Zaidi, Z., Zhu, L., Murray, C.J.L., Naghavi, M., Fitzmaurice, C.: The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015. JAMA ONCOLOGY. 3, 1683-1691 (2017).
Akinyemiju, Tomi, Abera, Semaw, Ahmed, Muktar, Alam, Noore, Alemayohu, Mulubirhan Assefa, Allen, Christine, Al-Raddadi, Rajaa, Alvis-Guzman, Nelson, Amoako, Yaw, Artaman, Al, Ayele, Tadesse Awoke, Barac, Aleksandra, Bensenor, Isabela, Berhane, Adugnaw, Bhutta, Zulfiqar, Castillo-Rivas, Jacqueline, Chitheer, Abdulaal, Choi, Jee-Young, Cowie, Benjamin, Dandona, Lalit, Dandona, Rakhi, Dey, Subhojit, Dicker, Daniel, Phuc, Huyen, Ekwueme, Donatus U., Zaki, Maysaa El Sayed, Fischer, Florian, Furst, Thomas, Hancock, Jamie, Hay, Simon I., Hotez, Peter, Jee, Sun Ha, Kasaeian, Amir, Khader, Yousef, Khang, Young-Ho, Kumar, G. Anil, Kutz, Michael, Larson, Heidi, Lopez, Alan, Lunevicius, Raimundas, Malekzadeh, Reza, McAlinden, Colm, Meier, Toni, Mendoza, Walter, Mokdad, Ali, Moradi-Lakeh, Maziar, Nagel, Gabriele, Nguyen, Quyen, Nguyen, Grant, Ogbo, Felix, Patton, George, Pereira, David M., Pourmalek, Farshad, Qorbani, Mostafa, Radfar, Amir, Roshandel, Gholamreza, Salomon, Joshua A., Sanabria, Juan, Sartorius, Benn, Satpathy, Maheswar, Sawhney, Monika, Sepanlou, Sadaf, Shackelford, Katya, Shore, Hirbo, Sun, Jiandong, Mengistu, Desalegn Tadese, Topor-Madry, Roman, Tran, Bach, Ukwaja, Kingsley Nnanna, Vlassov, Vasiliy, Vollset, Stein Emil, Vos, Theo, Wakayo, Tolassa, Weiderpass, Elisabete, Werdecker, Andrea, Yonemoto, Naohiro, Younis, Mustafa, Yu, Chuanhua, Zaidi, Zoubida, Zhu, Liguo, Murray, Christopher J. L., Naghavi, Mohsen, and Fitzmaurice, Christina. “The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015”. JAMA ONCOLOGY 3.12 (2017): 1683-1691.

3 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Liver Transplantation for Alcoholic Liver Disease and Hepatocellular Carcinoma.
Burra P, Zanetto A, Germani G., Cancers (Basel) 10(2), 2018
PMID: 29425151
Laryngeal cancer: Global socioeconomic trends in disease burden and smoking habits.
Ramsey T, Guo E, Svider PF, Lin H, Syeda S, Raza SN, Fribley AM., Laryngoscope (), 2018
PMID: 29508408
Impact of direct-acting antiviral agents on the risk for hepatocellular carcinoma.
Adhoute X, Castellani P, Bourlière M., Transl Gastroenterol Hepatol 2(), 2017
PMID: 29354767

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 28983565
PubMed | Europe PMC

Suchen in

Google Scholar